Download The Boston Criteria Version For Cerebral Amyloid Angiopathy Multicentre, Retrospective, Mriвђ“neuropathology Diagnostic Accuracy Study Pdf <Ultra HD>

The Boston criteria version 2.0 (v2.0) study improves cerebral amyloid angiopathy (CAA) diagnosis by incorporating non-hemorrhagic MRI markers like centrum semiovale perivascular spaces (CSO-PVS) and white matter hyperintensities, increasing sensitivity to 74.5%. This multicentre, retrospective study validated these updated criteria against neuropathology across diverse clinical scenarios, including cognitive impairment and transient focal neurological episodes. Access the full-text article at PMC .

The Boston criteria version 2.0 for cerebral amyloid angiopathy The Boston criteria version 2

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more increasing sensitivity to 74.5%. This multicentre